M. Hailey-Hailey: hSPCA1 Expression and Skin Structure Upon Laser Therapy
Hailey Hailey Disease
About this trial
This is an interventional basic science trial for Hailey Hailey Disease
Eligibility Criteria
Inclusion Criteria:
- Clinically diagnosed M. Hailey-Hailey as confirmed by histopathology and/or genetic analysis.
- Indication for ablative laser therapy
- >18 years old
- Informed consent
Exclusion Criteria:
- <18 years old
- Treatment with tetracyclines, topical hormones or oral retinoids within the last 30 days preceding participation
- Lack of informed consent
Sites / Locations
- Maastricht University Medical CenterRecruiting
Arms of the Study
Arm 1
Experimental
Hailey Hailey
Patients with Hailey Hailey, diagnosis confirmed by histopathology or genetics, with therapy resistant skin lesions suitable for ablative lasertherapy. Skin biopsy specimens will be taken before and after lasertherapy at three time points. Before treatment: Affected skin 4 mm punch for immunofluorescence and RNA extraction 2 mm for electron microscopy Healthy skin within same anatomical region 4 mm punch for immunofluorescence and RNA extraction Immediately after treatment of the treated area: 2 mm punch for histopathology Six weeks after treatment: Treated skin 4 mm punch for immunofluorescence and RNA extraction 2 mm for electron microscopy